Moderna
MRNA
#1228
Rank
$14.73 B
Marketcap
$38.29
Share price
3.65%
Change (1 day)
-51.51%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -$4.31 Billion USD

According to Moderna 's latest financial reports the company's current earnings are $4.98 Billion USD. In 2023 the company made an earning of -$3.91 Billion USD a decrease over its 2022 earnings that were of $9.60 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$4.31 Billion10.25%
2023 -$3.91 Billion-140.65%
2022 $9.60 B-27.81%
2021 $13.30 B-1911.15%
2020 -$0.74 Billion44.7%
2019 -$0.51 Billion28.63%
2018 -$0.4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$35 Million-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.49 B-483.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$41.77 Million-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.19 Billion-95.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.73 B-395.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$0.53 Billion-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.39 B-527.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.12 Billion-97.27%๐Ÿ‡บ๐Ÿ‡ธ USA